Biotech · Private company
Cortice Biosciences, Inc.
Track this companyFree. Adds Cortice Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- BevacizumabPhase 2 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- TPI 287Phase 2 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for GlioblastomaPHASE1_PHASE2 · SUSPENDED · started Aug 1, 2013ClinicalTrials.gov NCT01933815 · fetched Nov 12, 2026
- Safety and Efficacy Study of TPI-287 in Neuroblastoma and MedulloblastomaPHASE1_PHASE2 · TERMINATED · started Dec 1, 2011ClinicalTrials.gov NCT01483820 · fetched Nov 12, 2026
- Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed NeuroblastomaPHASE1_PHASE2 · TERMINATED · started Dec 1, 2011ClinicalTrials.gov NCT01505608 · fetched Nov 12, 2026
- TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or MedulloblastomaPHASE1 · COMPLETED · started Mar 1, 2009ClinicalTrials.gov NCT00867568 · fetched Nov 12, 2026